Niacinamide

Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000 Sep;143(3):524-31. Basic Research Laboratory, Kanebo Ltd, 5-3-28 Kotobuki-cho, Odawara-shi, Kanagawa 250-0002, Japan.

Bissett D. Topical niacinamide and barrier enhancement. Cutis. 2002 Dec;70(6 Suppl):8-12; discussion 21-3. Procter & Gamble Company, Cincinnati, Ohio, USA.

Soma Y, Kashima M, Imaizumi A, Takahama H, Kawakami T, Mizoguchi M. Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol. 2005 Mar;44(3):197-202. Department of Dermatology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.

Bissett DL, Oblong JE, Berge CA. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005 Jul;31(7 Pt 2):860-5; discussion 865. The Procter & Gamble Company, Miami Valley Laboratories, Cincinnati, Ohio 45252, USA.

Greatens A, Hakozaki T, Koshoffer A, Epstein H, Schwemberger S, Babcock G, Bissett D, Takiwaki H, Arase S, Wickett RR, Boissy RE. Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible. Exp Dermatol. 2005 Jul;14(7):498-508. Department of Dermatology, University of Cincinnati, OH, USA.

Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol. 1995 Jun;34(6):434-7. Department of Dermatology, State University of New York, College of Medicine, Brooklyn, USA.

Bernstein JE, Lorincz AL. The effects of topical nicotinamide, tetracycline, and dapsone on potassium iodide-induced inflammation. J Invest Dermatol 1980;74:25708.

Burger DR, Vandenbark AA, Daves D, Anderson WA Jr, Vetto RM, Finke P. Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor. J Immunol. 1976 Sep;117(3):797-801.

Binnick SA. Pityriasis rubra pilaris responding to aminonicotinamide. Arch Dermatol. 1978 Sep;114(9):1348-9.

Zackheim HS. Treatment of psoriasis with 6-aminonicotinamide. Arch Dermatol. 1975 Jul;111(7):880-2.

Comaish JS, Felix RH, McGrath H. Topically applied niacinamide in isoniazid-induced pellagra. Arch Dermatol. 1976 Jan;112(1):70-2.

Cooper SM, Wojnarowska F. Treatments of choice for bullous pemphigoid. Skin Therapy Lett. 2002 Jan;7(1):4-6. Department of Dermatology, Oxford Radcliffe Hospital, Oxford, UK.

Kreyden OP, Borradori L, Trueb RM, Burg G, Nestle FO. Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid. Hautarzt. 2001 Mar;52(3):247-50. Dermatologische Klinik des Universitatsspitals Zurich, Gloriastrasse 31, CH-8091 Zurich.

Mascaro JM Jr, Zillikens D, Giudice GJ, Caux F, Fleming MG, Katz HM, Diaz LA. A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: the first case report from the United States. J Am Acad Dermatol. 2000 Feb;42(2 Pt 2):309-15. Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226, USA.

Hornschuh B, Hamm H, Wever S, Hashimoto T, Schroder U, Brocker EB, Zillikens D. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol. J Am Acad Dermatol. 1997 Jan;36(1):101-3. Department of Dermatology, University of Wurzburg, Germany.

Mallon E, Wojnarowska F. Cicatricial pemphigoid presenting with unusual palmar involvement, successfully treated with a combination of nicotinamide and tetracycline. Clin Exp Dermatol. 1994 Nov;19(6):526-30. Department of Dermatology, Churchill Hospital, Oxford, UK.

Tischendorf L. Local nicotinamide therapy in erosive lichen of the oral mucosa. Stomatol DDR. 1978 Dec;28(12):911-4.

Zackheim HS. Topical 6-aminonicotinamide plus oral niacinamide therapy for psoriasis. Arch Dermatol. 1978 Nov;114(11):1632-8.

Jablonska S. Letter: Treatment of acne vulgaris and rosacea. Arch Dermatol. 1975 Jul;111(7):929.

Gensler HL. Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide. Nutr Cancer. 1997;29(2):157-62. Cancer Prevention and Control Program, Arizona Cancer Center, College of Medicine, University of Arizona, Tucson 85724, USA.

Gensler HL, Williams T, Huang AC, Jacobson EL. Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice. Nutr Cancer. 1999;34(1):36-41. Arizona Cancer Center, Department of Radiation Oncology, University of Arizona College of Medicine, Tucson 85724, USA.

MiGruet P, Gaillard C, Boisrame B, Duffaut D, Grimoud AM, Camy G. Use of an oral antiseptic bioadhesive tablet in dogs. J Vet Dent. 1995 Sep;12(3):87-91. VETOQUINOL Research Centre, Lure, France.

Troll W, Wiesner R, Frenkel K. Anticarcinogenic action of protease inhibitors. Adv Cancer Res. 1987;49:265-83. Department of Environmental Medicine, New York University Medical Center, New York 10016.

Licastro F, Walford RL. Modulatory effect of nicotinamide on unscheduled DNA synthesis in lymphocytes from young and old mice. Mech Ageing Dev. 1986 Jul;35(2):123-31.